PubMed · Vaccine· Jessica A Kahn·· 19 天前
公共卫生:Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women.
Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women.
AI 导读
原文摘录:BACKGROUND: The study aim was to examine trends in non-4-valent and non-9-valent vaccine-type HPV detection over the first 17 years after U.S. HPV vaccine introduction among young women. … CONCLUSIONS: We did not find evidence for cross-protection against types not targeted by the 4-valent or 9-valent vaccines, but did find a signal for possible emerging type replacement
来源:PubMed · Vaccine · pubmed.ncbi.nlm.nih.gov